The Prosthetic Heart Valve Market size was valued at USD 11.20 Billion in 2023 and the total Prosthetic Heart Valve revenue is expected to grow at a CAGR of 12.94 % from 2024 to 2030, reaching nearly USD 26.25 Billion by 2030. Prosthetic Heart Valves are artificial devices implanted into the heart to replace damaged or diseased natural valves, ensuring proper blood flow within the cardiac chambers. The Prosthetic Heart Valve Market is experiencing significant growth driven by an increase in cardiovascular diseases, aging populations, and technological advancements in valve design. As of the current scenario, the global Prosthetic Heart valve market is robust, with North America and Europe being major contributors due to a higher prevalence of heart diseases and advanced healthcare infrastructure. The increasing geriatric population, increased demand for minimally invasive surgeries, and innovations in valve design, such as tissue-engineered valves and transcatheter heart valves are the major Factors driving the Prosthetic Heart Valve Market growth. Recent developments involve key players such as Edwards Lifesciences, which launched the SAPIEN 3 Ultra transcatheter heart valve, showcasing enhanced sealing and delivery systems. Medtronic introduced the Intrepid Transcatheter Valve System, focusing on a minimally invasive approach with improved durability. Abbott Laboratories expanded its product portfolio with the Tendyne Transcatheter Mitral Valve Implantation system, catering to patients with mitral regurgitation. These innovations underscore the market's trajectory toward minimally invasive, more durable, and patient-tailored solutions, further propelling the growth and advancement of Prosthetic Heart Valve technologies. To know about the Research Methodology:-Request Free Sample ReportProsthetic Heart Valve Market Dynamics:
Rising Preference for Minimally Invasive Procedures with Emerging Economies' Healthcare Infrastructure Driving Prosthetic Heart Valve Market Growth The speedy growth in cardiovascular ailments globally, such as valvular heart diseases and congenital heart defects, drive the demand for Prosthetic Heart Valves. For instance, the American Heart Association reported over 5 million Americans are diagnosed with heart valve disease annually, driving Prosthetic Heart Valve Market growth for devices such as Edwards Lifesciences' SAPIEN transcatheter heart valves. The rising elderly demographic prone to heart-related complications boosts the Prosthetic Heart Valve Market growth. With advancing age, the prevalence of heart valve diseases rises. For example, in Europe, where approximately 13% of the population is aged 65 or older, there's a growing demand for prosthetic valves like the Perceval Sutureless Valve by LivaNova catering to elderly patients. Ongoing innovations, such as minimally invasive transcatheter heart valve replacements, drive market growth, advancements such as Medtronic's Evolut TAVR platform, offering improved valve designs and easier deployment, enhancing patient outcomes and increasing adoption rates. The inclination towards minimally invasive surgeries for heart valve replacements amplifies Prosthetic Heart Valve Market growth. For instance, Abbott's MitraClip, a transcatheter mitral valve repair system, offers a less invasive option for treating mitral regurgitation, attracting patients seeking alternatives to open-heart surgery. Continuous approvals by regulatory bodies for newer valve technologies accelerate market growth. The FDA's approval of Edwards Lifesciences' SAPIEN 3 Ultra System in 2021, with enhanced features for transcatheter aortic valve replacement (TAVR), led to increased adoption rates. Growing healthcare spending worldwide drives investment in advanced cardiac care, including prosthetic heart valves. Countries such as Japan, with substantial healthcare expenditures, witness higher adoption rates of devices like Medtronic's CoreValve, augmenting market growth. Improving healthcare infrastructure in emerging economies supports market expansion. Companies like Boston Scientific introducing the ACURATE neo2 aortic valve in India capitalize on this growth potential, fulfilling to a larger patient base. High Cost of Treatment with Risk of Thromboembolism and Bleeding Hinders the Prosthetic Heart Valves Market Growth The Prosthetic Heart Valve Market encounters various significant restraints impacting accessibility and adoption. The substantial costs associated with procedures pose a financial barrier, limiting accessibility to transcatheter valve replacements such as Edwards Lifesciences' SAPIEN valves, particularly among certain demographics. Durability issues, while mechanical valves like those by On-X Life Technologies are durable, entail lifelong anticoagulation therapy, posing challenges and risks for patients. Patients using mechanical valves face heightened risks of blood clotting and bleeding, impacting treatment decisions and necessitating regular monitoring. Some prosthetic valves are unsuitable for minimally invasive procedures, constraining their utilization in transcatheter replacements. The lack of pediatric-specific valve options, like Edwards Lifesciences' pediatric SAPIEN valves, limits treatment choices. Challenges in accurately sizing valves for individual patients, instances of structural valve deterioration, stringent regulatory processes, inadequate reimbursement policies, and the complexity of newer valve technologies demanding specialized expertise further compound challenges in this market, hindering widespread adoption and accessibility. These hurdles collectively impede the seamless integration and utilization of advanced prosthetic heart valve technologies, presenting formidable challenges for manufacturers, healthcare providers, and patients seeking optimal treatment options.Prosthetic Heart Valve Market Segment Analysis:
Based on Type, Mechanical valves dominated the Prosthetic Heart Valve Market in 2023 as they are durable but necessitating lifelong anticoagulation therapy, find use among patients requiring long-term valve replacements. Bioprosthetic valves is a fast-growing segment in the Prosthetic Heart Valve Market, they are made from biological tissues, fulfilling to patients unwilling or unable to commit to lifelong medications, commonly used in elderly or pediatric cases due to reduced need for anticoagulation. Transcatheter valves, offering minimally invasive procedures, are preferred for patients at high surgical risk or those seeking less invasive treatments. Their adoption is rapidly increasing due to technological advancements and favorable outcomes in treating valve diseases. While mechanical valves provide durability, bioprosthetic valves offer fewer complications regarding anticoagulation, and transcatheter valves present minimally invasive options, each type presents a trade-off between longevity, need for medication, and invasiveness, influencing their application and adoption in treating various cardiac conditions. Based on Position, Mitral valves dominated the Prosthetic Heart Valve Market with 39 % market share in 2023. They addressing mitral regurgitation or stenosis, witness significant adoption due to the prevalence of mitral valve diseases. Aortic valves, crucial for aortic regurgitation or stenosis treatments, observe high application rates owing to the prevalence of aortic valve disorders. Valves for Other Positions, encompassing tricuspid or pulmonary positions, have comparatively lower application rates, often utilized in less common heart conditions or combined valve diseases. The adoption patterns vary concerning the complexity and frequency of diseases related to specific valve positions. Mitral and aortic valve replacements remain more common due to their higher disease incidence, whereas Other Positions, addressing less frequent heart valve issues, exhibit relatively lower adoption rates within the prosthetic heart valve market.Prosthetic Heart Valve Market Regional Insights:
North America Dominance in the Prosthetic Heart Valve Market North America and Europe act as primary production hubs, developing advanced healthcare infrastructure, robust R&D capabilities, and widespread adoption of innovative medical technologies in the Prosthetic Heart Valve Market. Renowned manufacturers such as Edwards Lifesciences and Medtronic, entrenched in these regions, notably elevate global production levels. Both North America and Europe serve as pivotal operating centers, driven by a high incidence of cardiovascular diseases and superior access to advanced medical interventions. For instance, the United States commands a significant market share within North America, attributed to increasing instances of heart valve disorders, advancements in products, and a well-established healthcare system. For example, reports from the 2022 American College of Cardiology Foundation indicate over 5 million annual diagnoses of valvular heart diseases (VHD) in the US, including 1.5 million cases of aortic stenosis (AS), with 500,000 cases classified as severe AS. Strategic endeavors by Prosthetic Heart Valve Market players, such as Abbott's USFDA-approved Epic Plus and Epic Plus Supra Stented Tissue Valves in September 2021, stimulate growth in the United States Prosthetic Heart Valve Market. The Asia-Pacific region, particularly countries such as China and India, prominently engages in importing prosthetic heart valves due to rising healthcare expenditure, an increasing elderly population, and increased awareness of cardiac care. These nations heavily rely on imports from North American and European manufacturers to meet local demands. North America and Europe play substantial roles as exporting hubs, catering to the mounting needs of emerging markets in Asia-Pacific and the Middle East.Scope of the Prosthetic Heart Valve Market Report: Inquire before buying
Global Prosthetic Heart Valve Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 11.20 Bn. Forecast Period 2024 to 2030 CAGR: 12.94% Market Size in 2030: US $ 26.25 Bn. Segments Covered: by Product Robotic Waterjet Cutting Micro Waterjet Cutting 3D Waterjet Cutting by Technology Pure Waterjet Cutting Technology Abrasive Waterjet Cutting Technology by Machine Size Small Medium Large by Application Automotive Defense and Aerospace Metal Fabrication Electronics Textile Interior Decoration Others Prosthetic Heart Valve Market by Region:
North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and the Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A) South America (Brazil, Argentina Rest of South America)Prosthetic Heart Valve Market Key Players:
Major Contributors in the Prosthetic Heart Valve Industry in North America: 1. Edwards Lifesciences Corporation, Irvine, California, United States 2. Abbott Laboratories Abbott Park, Illinois, USA 3. Boston Scientific Corporation Marlborough, Massachusetts, USA 4. Colibri Heart Valve, Broomfield, Colorado, USA 5. CryoLife, Inc. Kennesaw, Georgia, United States 6. JenaValve Technology, Inc., Irvine, California, USA 7. ValveXchange, Inc. Lake Forest, California, USA Leading players in the Europe Prosthetic Heart Valve Market: 1. Medtronic plc Dublin, Ireland 2. LivaNova PLC London, UK 3. Biotronik SE & Co. KG Berlin, Germany 4. B. Braun Melsungen AG, Melsungen, Germany 5. Sulzer AG Winterthur, Switzerland 6. Perouse Medical, Meylan, France 7. Sorin Group Milan, Italy 8. Symetis SA, Ecublens, Switzerland Key players driving the Asia-Pacific Prosthetic Heart Valve market: 1. Lepu Medical Technology, Beijing, China 2. MicroPort Scientific Corporation, Shanghai, China 3. Meril Life Sciences, Mumbai, India 4. Teijin Limited Tokyo, Japan 5. Admedus Limited Brisbane, Australia 6. Shanghai MicroPort Endovascular Medtech Co., Ltd Shanghai, China 7. Venus Medtech, Hangzhou, China Dominant players spearheading growth in the South America Prosthetic Heart Valve market 1. Braile Biomédica, São José do Rio Preto, Brazil 2. Biointeractions Ltda, Cotia, Brazil FAQs: 1] What segments are covered in the Global Market report? Ans. The segments covered in the Market report are based on Type, Position, End Users and Region. 2] Which region is expected to hold the highest share in the Global Market? Ans. North America region is expected to hold the highest share in the market. 3] What is the market size of the Global Market by 2030? Ans. The market size of the Market by 2030 is expected to reach US$ 26.25 Bn. 4] What is the forecast period for the Global Market? Ans. The forecast period for the Market is 2024-2030. 5] What was the market size of the Global Market in 2023? Ans. The market size of the Market in 2023 was valued at US$ 11.20 Bn.
1. Prosthetic Heart Valve Market: Research Methodology 2. Prosthetic Heart Valve Market Introduction 2.1. Study Assumption and Market Definition 2.2. Scope of the Study 2.3. Executive Summary 3. Prosthetic Heart Valve Market: Dynamics 3.1. Prosthetic Heart Valve Market Trends by Region 3.1.1. North America Prosthetic Heart Valve Market Trends 3.1.2. Europe Prosthetic Heart Valve Market Trends 3.1.3. Asia Pacific Prosthetic Heart Valve Market Trends 3.1.4. Middle East and Africa Prosthetic Heart Valve Market Trends 3.1.5. South America Prosthetic Heart Valve Market Trends 3.2. Prosthetic Heart Valve Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Prosthetic Heart Valve Market Drivers 3.2.1.2. North America Prosthetic Heart Valve Market Restraints 3.2.1.3. North America Prosthetic Heart Valve Market Opportunities 3.2.1.4. North America Prosthetic Heart Valve Market Challenges 3.2.2. Europe 3.2.2.1. Europe Prosthetic Heart Valve Market Drivers 3.2.2.2. Europe Prosthetic Heart Valve Market Restraints 3.2.2.3. Europe Prosthetic Heart Valve Market Opportunities 3.2.2.4. Europe Prosthetic Heart Valve Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Prosthetic Heart Valve Market Drivers 3.2.3.2. Asia Pacific Prosthetic Heart Valve Market Restraints 3.2.3.3. Asia Pacific Prosthetic Heart Valve Market Opportunities 3.2.3.4. Asia Pacific Prosthetic Heart Valve Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Prosthetic Heart Valve Market Drivers 3.2.4.2. Middle East and Africa Prosthetic Heart Valve Market Restraints 3.2.4.3. Middle East and Africa Prosthetic Heart Valve Market Opportunities 3.2.4.4. Middle East and Africa Prosthetic Heart Valve Market Challenges 3.2.5. South America 3.2.5.1. South America Prosthetic Heart Valve Market Drivers 3.2.5.2. South America Prosthetic Heart Valve Market Restraints 3.2.5.3. South America Prosthetic Heart Valve Market Opportunities 3.2.5.4. South America Prosthetic Heart Valve Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technological Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis for Prosthetic Heart Valve End User 3.8. Analysis of Government Schemes and Initiatives for the Prosthetic Heart Valve Market 3.9. The Global Pandemic Impact on Prosthetic Heart Valve Market 4. Prosthetic Heart Valve Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 4.1.1. Mechanical Heart Valve 4.1.2. Bioprosthetic Heart Valve 4.1.3. Transcatheter Heart Valve 4.2. Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 4.2.1. Mitral Valve 4.2.2. Aortic Valve 4.2.3. Other Positions 4.3. Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 4.3.1. Hospitals 4.3.2. Ambulatory Surgical Centers (ASCs) 4.3.3. Cardiac Catheterization Laboratories 4.3.4. Research and Academic Institutions 4.3.5. Medical Device Companies 4.4. Prosthetic Heart Valve Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Prosthetic Heart Valve Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. North America Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 5.1.1. Mechanical Heart Valve 5.1.2. Bioprosthetic Heart Valve 5.1.3. Transcatheter Heart Valve 5.2. North America Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 5.2.1. Mitral Valve 5.2.2. Aortic Valve 5.2.3. Other Positions 5.3. North America Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 5.3.1. Hospitals 5.3.2. Ambulatory Surgical Centers (ASCs) 5.3.3. Cardiac Catheterization Laboratories 5.3.4. Research and Academic Institutions 5.3.5. Medical Device Companies 5.4. Prosthetic Heart Valve Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 5.4.1.1.1. Robotic Waterjet Cutting 5.4.1.1.2. Micro Waterjet Cutting 5.4.1.1.3. 3D Waterjet Cutting 5.4.1.2. United States Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 5.4.1.2.1. Pure Waterjet Cutting Position 5.4.1.2.2. Abrasive Waterjet Cutting Position 5.4.1.3. United States Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 5.4.1.3.1. Small 5.4.1.3.2. Medium 5.4.1.3.3. Large 5.4.1.4. United States Prosthetic Heart Valve Market Size and Forecast, by Application (2023-2030) 5.4.1.4.1. Automotive 5.4.1.4.2. Defense and Aerospace 5.4.1.4.3. Metal Fabrication 5.4.1.4.4. Electronics 5.4.1.4.5. Textile 5.4.1.4.6. Interior Decoration 5.4.1.4.7. Others 5.4.2. Canada 5.4.2.1. Canada Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 5.4.2.1.1. Bioprosthetic Heart Valve 5.4.2.1.2. Transcatheter Heart Valve 5.4.2.2. Canada Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 5.4.2.2.1. Mitral Valve 5.4.2.2.2. Aortic Valve 5.4.2.2.3. Other Positions 5.4.2.3. Canada Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 5.4.2.3.1. Hospitals 5.4.2.3.2. Ambulatory Surgical Centers (ASCs) 5.4.2.3.3. Cardiac Catheterization Laboratories 5.4.2.3.4. Research and Academic Institutions 5.4.2.3.5. Medical Device Companies 5.4.3. Mexico 5.4.3.1. Mexico Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 5.4.3.1.1. Mechanical Heart Valve 5.4.3.1.2. Bioprosthetic Heart Valve 5.4.3.1.3. Transcatheter Heart Valve 5.4.3.2. Mexico Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 5.4.3.2.1. Mitral Valve 5.4.3.2.2. Aortic Valve 5.4.3.2.3. Other Positions 5.4.3.3. Mexico Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 5.4.3.3.1. Hospitals 5.4.3.3.2. Ambulatory Surgical Centers (ASCs) 5.4.3.3.3. Cardiac Catheterization Laboratories 5.4.3.3.4. Research and Academic Institutions 5.4.3.3.5. Medical Device Companies 6. Europe Prosthetic Heart Valve Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Europe Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.2. Europe Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.3. Europe Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 6.4. Europe Prosthetic Heart Valve Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.4.1.2. United Kingdom Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.4.1.3. United Kingdom Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 6.4.2. France 6.4.2.1. France Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.4.2.2. France Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.4.2.3. France Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.4.3.2. Germany Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.4.3.3. Germany Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.4.4.2. Italy Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.4.4.3. Italy Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.4.5.2. Spain Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.4.5.3. Spain Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.4.6.2. Sweden Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.4.6.3. Sweden Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.4.7.2. Austria Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.4.7.3. Austria Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 6.4.8.2. Rest of Europe Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 6.4.8.3. Rest of Europe Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7. Asia Pacific Prosthetic Heart Valve Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.2. Asia Pacific Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.3. Asia Pacific Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4. Asia Pacific Prosthetic Heart Valve Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.1.2. China Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.1.3. China Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.2.2. S Korea Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.2.3. S Korea Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.3.2. Japan Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.3.3. Japan Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.4. India 7.4.4.1. India Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.4.2. India Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.4.3. India Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.5.2. Australia Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.5.3. Australia Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.6.2. Indonesia Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.6.3. Indonesia Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.7.2. Malaysia Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.7.3. Malaysia Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.8.2. Vietnam Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.8.3. Vietnam Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.9.2. Taiwan Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.9.3. Taiwan Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 7.4.10.2. Rest of Asia Pacific Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 7.4.10.3. Rest of Asia Pacific Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 8. Middle East and Africa Prosthetic Heart Valve Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 8.1. Middle East and Africa Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 8.2. Middle East and Africa Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 8.3. Middle East and Africa Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 8.4. Middle East and Africa Prosthetic Heart Valve Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 8.4.1.2. South Africa Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 8.4.1.3. South Africa Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 8.4.2.2. GCC Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 8.4.2.3. GCC Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 8.4.3. Nigeria 8.4.3.1. Nigeria Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 8.4.3.2. Nigeria Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 8.4.3.3. Nigeria Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 8.4.4.2. Rest of ME&A Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 8.4.4.3. Rest of ME&A Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 8.4.4.4. Rest of ME&A Prosthetic Heart Valve Market Size and Forecast, by Application (2023-2030) 9. South America Prosthetic Heart Valve Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 9.1. South America Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 9.2. South America Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 9.3. South America Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 9.4. South America Prosthetic Heart Valve Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 9.4.1.2. Brazil Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 9.4.1.3. Brazil Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 9.4.2.2. Argentina Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 9.4.2.3. Argentina Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Prosthetic Heart Valve Market Size and Forecast, by Type (2023-2030) 9.4.3.2. Rest Of South America Prosthetic Heart Valve Market Size and Forecast, by Position (2023-2030) 9.4.3.3. Rest Of South America Prosthetic Heart Valve Market Size and Forecast, by End User (2023-2030) 10. Global Prosthetic Heart Valve Market: Competitive Landscape 10.1. MMR Competition Matrix 10.2. Competitive Landscape 10.3. Key Players Benchmarking 10.3.1. Company Name 10.3.2. Service Segment 10.3.3. End-user Segment 10.3.4. Revenue (2022) 10.3.5. Company Locations 10.4. Leading Prosthetic Heart Valve Market Companies, by Market Capitalization 10.5. Market Structure 10.5.1. Market Leaders 10.5.2. Market Followers 10.5.3. Emerging Players 10.6. Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1. Edwards Lifesciences Corporation, Irvine, California, United States 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis 11.1.5. Strategic Analysis 11.1.6. Scale of Operation (Small, Medium, and Large) 11.1.7. Details on Partnership 11.1.8. Regulatory Accreditations and Certifications Received by Them 11.1.9. Awards Received by the Firm 11.1.10. Recent Developments 11.2. Abbott Laboratories Abbott Park, Illinois, USA 11.3. Boston Scientific Corporation Marlborough, Massachusetts, USA 11.4. Colibri Heart Valve Broomfield, Colorado, USA 11.5. CryoLife, Inc. Kennesaw, Georgia, United States 11.6. JenaValve Technology, Inc. Irvine, California, USA 11.7. ValveXchange, Inc. Lake Forest, California, USA 11.8. Medtronic plc Dublin, Ireland 11.9. LivaNova PLC London, UK 11.10. Biotronik SE & Co. KG Berlin, Germany 11.11. B. Braun Melsungen AG Melsungen, Germany 11.12. Sulzer AG Winterthur, Switzerland 11.13. Perouse Medical Meylan, France 11.14. Sorin Group Milan, Italy 11.15. Symetis SA Ecublens, Switzerland 11.16. Lepu Medical Technology Beijing, China 11.17. MicroPort Scientific Corporation Shanghai, China 11.18. Meril Life Sciences Mumbai, India 11.19. Teijin Limited Tokyo, Japan 11.20. Admedus Limited Brisbane, Australia 11.21. Shanghai MicroPort Endovascular Medtech Co., Ltd Shanghai, China 11.22. Venus Medtech Hangzhou, China 11.23. Braile Biomédica São José do Rio Preto, Brazil 11.24. Biointeractions Ltda Cotia, Brazil 12. Key Findings 13. End User Recommendations